Tdspharm

Tdspharm develops and manufactures transdermal drug-delivery patches, adhesive patches applied to the skin that release medication steadily into the body, reducing side effects and improving patient convenience.

Listed on KOSDAQ, Korea's tech and small-cap board, it supplies pharmaceutical companies that market the finished products under their own brands, primarily through contract manufacturing arrangements. Its core business is concentrated in cataplasma (medicated gel patches) and plaster-type patches, and it is expanding its patch portfolio beyond anti-inflammatory pain relief into areas such as dementia, asthma, nicotine, and pain management.